Immunogenicity of therapeutic proteins. Part 2: Impact of container closures
- 30 January 2007
- journal article
- review article
- Published by Elsevier
- Vol. 25 (3) , 318-324
- https://doi.org/10.1016/j.biotechadv.2007.01.006
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringesKidney International, 2005
- Accumulation of extractables in buffer solutions from a polyolefin plastic containerInternational Journal of Pharmaceutics, 2005
- Silicone Oil Induced Aggregation of ProteinsJournal of Pharmaceutical Sciences, 2005
- Plasticizers, antioxidants, and other contaminants found in air delivered by PVC tubing used in respiratory therapyBiomedical Chromatography, 2003
- Immune Responses to Therapeutic Proteins in Humans - Clinical Significance, Assessment and PredictionCurrent Pharmaceutical Biotechnology, 2002
- Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant ErythropoietinNew England Journal of Medicine, 2002
- The clinical effects of plasticizers, antioxidants, and other contaminants in medical polyvinylchloride tubing during respiratory and non-respiratory exposureClinica Chimica Acta; International Journal of Clinical Chemistry, 2001
- Effect of Type of Container, Storage Temperature and Humidity on the Biological Activity of Freeze-dried Alkaline PhosphataseBiologicals, 1994
- Identification of Sites of Degradation in a Therapeutic Monoclonal Antibody by Peptide MappingPharmaceutical Research, 1992
- Demonstration of Insulin Transformation Products in Insulin Vials by High-Performance Liquid ChromatographyDiabetes Care, 1991